Requisite Capital Management’s Gilead Sciences GILD Stock Holding History

Requisite Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,900	Closed	-$223K	–	74
2020 Q2	$223K	Hold	2,900	–	–	0.09%	55
2020 Q1	$217K	Sell	2,900 -3,000	-51%	-$207K	0.09%	46
2019 Q4	$383K	Hold	5,900	–	–	0.13%	51
2019 Q3	$374K	Hold	5,900	–	–	0.14%	58
2019 Q2	$399K	Buy	5,900 +1,000	+20%	+$65.8K	0.16%	56
2019 Q1	$319K	Buy	+4,900	New	+$326K	0.12%	55

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Requisite Capital Management's GILD Position: Q3 2020 in Review

Requisite Capital Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,900 shares — an estimated $223K sold.

Requisite Capital Management first reported a position in GILD in Q1 2019 and held it in 6 quarters. The position peaked at $399K in Q2 2019. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

Requisite Capital Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
Requisite Capital Management sold 2,900 Gilead Sciences shares in Q3 2020, an estimated $223K.
Requisite Capital Management first reported a position in Gilead Sciences in Q1 2019 and held it in 6 quarters.
Requisite Capital Management's Gilead Sciences position peaked at $399K in Q2 2019.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Requisite Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.